Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study Assessing the Ocular and Systemic Safety and Systemic Absorption of H1337 Ophthalmic Solution, 1% in Healthy Volunteers

NCT06572397 is registered in ClinicalTrials.gov with D. Western Therapeutics Institute, Inc. as lead sponsor.

NCT NCT06572397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06572397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study Assessing the Ocular and Systemic Safety and Systemic Absorption of H1337 Ophthalmic Solution, 1% in Healthy Volunteers
Lead sponsor
D. Western Therapeutics Institute, Inc.
Phase
Phase 1
Overall status
Completed
Start date
September 16, 2024
Completion date
October 14, 2024
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma open-angle primary, ocular hypertension